[Federal Register Volume 87, Number 158 (Wednesday, August 17, 2022)]
[Notices]
[Pages 50633-50635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17720]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer on (240) 276-0361.
    Comments are invited on: (a) whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project: Program Evaluation for Prevention Contract (PEPC)--
Strategic Prevention Framework for Prescription Drugs (SPF-Rx) 
Evaluation (OMB No. 0930-0377)--Revision

    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to complete 
a cross-site evaluation of SAMHSA's SPF-Rx grant program. SPF-Rx is 
designed to address nonmedical use of prescription drugs as well as 
opioid overdoses by raising awareness about the dangers of sharing 
medications and by working with pharmaceutical and medical communities 
on the risks of overprescribing. The SPF-Rx program aims to promote 
collaboration between states/tribes and pharmaceutical and

[[Page 50634]]

medical communities to understand the risks of overprescribing to youth 
ages 12-17 and adults 18 years of age and older. The program also aims 
to enhance capacity for, and access to, Prescription Drug Monitoring 
Program (PDMP) data for prevention purposes. This request for data 
collection includes a revision from previously approved Office of 
Management and Budget (OMB) instruments.
    The SPF-Rx program's indicators of success are reductions in opioid 
overdoses, reduction in prescription drug misuse and improved use of 
PDMP data. Data collected through the tools described in this statement 
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx 
program. This package covers continued data collection through 2023. 
The Program Evaluation for Prevention Control (PEPC) team will 
systematically collect and maintain an Annual Reporting Tool (ART) and 
Grantee and Community Level Outcomes data modules submitted by SPF-Rx 
grantees through the online Data Management System (DMS).
    SAMHSA is requesting approval for data collection for the SPF-Rx 
cross-site evaluation with the following instruments:
    Annual Reporting Tool (ART)--The ART is a survey instrument 
collected yearly to monitor state, tribal entity, and community-level 
performance, and to evaluate the effectiveness of the SPF-Rx program. 
This tool is completed by grantees and sub-recipient community project 
directors and provides process data related to funding use and 
effectiveness, organizational capacity, collaboration with community 
partners, data infrastructure, planned intervention targets, 
intervention implementation, evaluation, contextual factors, training 
and technical assistance (T/TA) needs, and sustainability.
    Grantee-and Community-Level Outcomes Modules--These modules collect 
data on key SPF-Rx program outcomes, including opioid prescribing 
patterns and provider use of PDMP. Grantees will provide outcomes data 
at the grantee level for their state, tribal area, or jurisdiction, as 
well as at the community level for each of their sub-recipient 
communities.
    Grantee-Level Interview--This qualitative interview will be 
administered at the end of the evaluation to obtain information from 
the grantee project directors on their programs, staffing, populations 
of focus, infrastructure, capacity, lessons learned, and collaboration.

Annualized Data Collection Burden by Year

----------------------------------------------------------------------------------------------------------------
                                     Number of     Responses per   Total number      Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool...........          \a\110               1             110               4             440
                                          \b\ 21               1              21               3              63
Grantee-Level PDMP Outcomes               \b\ 21               1              21             2.5            52.5
 Module.........................
Community-Level PDMP Outcomes             \b\ 21             5.2             110            1.25           137.5
 Module.........................
Grantee-Level Interview.........          \b\ 21               1              21             1.5            31.5
                                 -------------------------------------------------------------------------------
FY2023..........................             131  ..............             283  ..............           724.5
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.


----------------------------------------------------------------------------------------------------------------
                                     Number of     Responses per   Total number      Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool...........         \a\ 110               1             110               4             440
                                          \b\ 21               1              21               3              63
Grantee-Level PDMP Outcomes               \b\ 21               1              21             2.5            52.5
 Module.........................
Community-Level PDMP Outcomes             \b\ 21             5.2             110            1.25           137.5
 Module.........................
Grantee-Level Interview.........           \b\ 0             N/A             N/A             1.5             N/A
                                 -------------------------------------------------------------------------------
FY2024..........................             131  ..............             283  ..............             693
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.


----------------------------------------------------------------------------------------------------------------
                                     Number of     Responses per   Total number      Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool...........         \a\ 110               1             110               4             440
                                          \b\ 21               1              21               3              63
Grantee-Level PDMP Outcomes               \b\ 21               1              21             2.5            52.5
 Module.........................
Community-Level PDMP Outcomes             \b\ 21             5.2             110            1.25           137.5
 Module.........................
Grantee-Level Interview.........          \b\ 21               1              21             1.5            31.5
                                 -------------------------------------------------------------------------------
FY2025..........................             131  ..............             283  ..............           724.5
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.


[[Page 50635]]

    Send comments to Carlos Graham, SAMHSA Reports Clearance Officer, 
5600 Fishers Lane, Room 15E57-A, Rockville, Maryland 20857, OR email a 
copy to [email protected]. Written comments should be 
received by October 17, 2022.

Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-17720 Filed 8-16-22; 8:45 am]
BILLING CODE 4162-20-P